1. Home
  2. CMCO vs APLT Comparison

CMCO vs APLT Comparison

Compare CMCO & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbus McKinnon Corporation

CMCO

Columbus McKinnon Corporation

HOLD

Current Price

$17.80

Market Cap

492.7M

Sector

Industrials

ML Signal

HOLD

Logo Applied Therapeutics Inc.

APLT

Applied Therapeutics Inc.

HOLD

Current Price

$0.12

Market Cap

38.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMCO
APLT
Founded
1875
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
492.7M
38.1M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
CMCO
APLT
Price
$17.80
$0.12
Analyst Decision
Hold
Hold
Analyst Count
1
3
Target Price
$35.00
$1.25
AVG Volume (30 Days)
243.6K
27.2M
Earning Date
10-30-2025
11-13-2025
Dividend Yield
1.57%
N/A
EPS Growth
N/A
N/A
EPS
0.13
N/A
Revenue
$977,994,000.00
$1,000,000.00
Revenue This Year
$5.60
$124.18
Revenue Next Year
$4.23
$66.67
P/E Ratio
$136.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.78
$0.11
52 Week High
$40.39
$1.50

Technical Indicators

Market Signals
Indicator
CMCO
APLT
Relative Strength Index (RSI) 67.24 25.40
Support Level $16.62 $0.21
Resistance Level $17.49 $0.26
Average True Range (ATR) 0.58 0.02
MACD 0.18 0.02
Stochastic Oscillator 91.47 5.13

Price Performance

Historical Comparison
CMCO
APLT

About CMCO Columbus McKinnon Corporation

Columbus McKinnon Corp is a designer, manufacturer, and marketer of intelligent motion solutions, including motion control products, technologies, automated systems, and services that efficiently and ergonomically move, lift, position, and secure materials. Its key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. The company's targeted market verticals include general industries, process industries, industrial automation, and e-commerce/supply chain/warehousing among others. Geographically, the company generates a majority of its revenue from the United States and the rest from Germany, Canada, Asia Pacific, Latin America, Europe, the Middle East, and Africa.

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Share on Social Networks: